Erin Seder Warren is a distinguished regulatory and public policy leader with deep expertise in tobacco harm reduction and life sciences. She currently leads efforts focused on advancing smoke-free alternatives, grounded in rigorous scientific evidence and public health impact, for Philip Morris International in the United States as the External Affairs, Head of Regulatory and Public Policy.
Throughout her career, Erin has held significant legal and policy leadership positions across the tobacco, nicotine, and cannabis sectors. Her work has shaped regulatory strategy, guided product innovation, and influenced legislative and agency engagement at the highest levels. She is known for her ability to navigate complex regulatory environments, mitigate business risk, and drive cross-functional collaboration in support of consumer safety and corporate integrity.
Erin’s approach is defined by strategic foresight, evidence-based advocacy, and a commitment to transparent stakeholder engagement. She has led initiatives addressing youth access prevention, product integrity, and regulatory compliance, and has been a trusted advisor during high-profile enforcement actions and public health debates.
A graduate of the University of Richmond School of Law and the University of Maryland, Erin brings a unique blend of legal acumen, policy insight, and operational leadership to her work. Outside of work, Erin is a devoted mom who loves cheering at her 10-year-old son’s music gigs alongside her husband. She’s also an avid gardener and sometimes golfer—though she admits her short game is mostly three putts and a prayer.
Shrey Grover is the strategy leader at Marsh Cyber UK, where he shapes the development of business-led products and propositions designed to deliver distinctive value to clients navigating an increasingly complex cyber risk landscape. A core part of his role is leading and supporting teams across the business, bringing together diverse expertise to translate strategy into execution. His work sits at the intersection of commercial strategy, client advisory, and innovation — translating market dynamics into propositions that resonate with the most sophisticated buyers of cyber insurance. Shrey is particularly interested in the role of artificial intelligence as a catalyst for enterprise productivity: how organisations can move beyond experimentation to embed AI thoughtfully and durably into how they operate and serve clients. He brings a perspective shaped by close engagement with senior stakeholders globally and a conviction that competitive advantage comes from disciplined strategy paired with genuine curiosity about what comes next.
With 18 years of experience in multinational pharmaceutical companies and CROs, including Roche, GlaxoSmithKline, Sanofi, and Kandiya, she specializes in regulatory affairs and registration strategy for innovative drugs and biologics in China. As Head of the Registration Affairs and Strategy Department, Susan Kong leads end-to-end product registration planning from IND to NDA, overseeing lifecycle regulatory pathways. Her expertise spans oncology, immunology, anti-infectives, CNS, and respiratory diseases, with deep knowledge of Chinese and U.S. regulatory requirements and extensive experience in global drug registration processes.
Dr. Dow is a board-certified Medical Oncologist with over 30 years of experience in clinical research and medicine, including classic chemotherapy agents, and modern products like molecular-targeted, checkpoint inhibitors and vaccines. Skilled in solid tumor studies both from a safety and response assessment perspective, Dow has led many FIH and early phase study in a wide variety of relapsed/refractory solid tumors providing not only medical monitoring but a strategic medical disease-oriented approach.
Brian Weinhaus is the Director of Illicit Trade Prevention for the United States at Philip Morris International (PMI), where he leads strategic efforts to combat illegal trade and protect the integrity of the company’s supply chain. His work focuses on complex investigations, risk mitigation, and building strong cross‑sector partnerships with government and industry stakeholders.
With deep expertise in brand protection, intelligence, and stakeholder engagement, Brian collaborates closely with law enforcement and regulatory partners to address global challenges related to counterfeiting, smuggling, and organized illicit networks. Prior to joining PMI, Brian held senior leadership roles at Moderna and with Homeland Security Investigations, where he directed large‑scale international investigations and intelligence programs, bringing more than two decades of experience in federal law enforcement and corporate security to his current role.
Dr. Cheryl Olson is a behavioral scientist internationally recognized for her work on health risk behaviors and the influence of media on youth. She earned a doctorate in health and social behavior from the Harvard School of Public Health, and a master’s degree in community health education from the University of Minnesota. Cheryl spent 15 years on the psychiatry faculty at Massachusetts General Hospital/Harvard Medical School, where she co-directed the Center for Mental Health and Media.
Along with academic work, Cheryl has decades of experience making scientific content meaningful and engaging for a variety of target audiences. She has written/edited a half-dozen popular books on health, and several dozen scientific articles. Her work has appeared in the New York Times, Parents magazine, WNYC (NPR) and Tobacco Reporter. She has advised foundations, universities, politicians and companies on health communication and engagement strategies.
Cheryl’s work in tobacco/nicotine includes developing the influential QuitAssist smoking cessation program for Philip Morris USA, and a CME course on tobacco harm reduction for Physicians Research Institute. As a consultant with McKinney Regulatory Science Advisors, she designed and conducted perception/intention studies on various reduced-risk nicotine products; some involved vulnerable groups such as people in custody and older persons who smoke. Cheryl currently works as a regulatory scientist for Womble Bond Dickinson, based remotely in Richmond, Virginia.
Mark Crouse is an Industry Executive Advisor at SAP with responsibilities for the Mining and Metals Industries. With over 41 years’ experience in the software industry and almost three decades in these industries he has seen several generations of technology and advised customer on when, how and why to leverage the ever-changing technology landscape to improve their business outcomes. Specific to asset management his father was an airline mechanic for 35-years, so he grew up in a household where terms like PRE, PdM, RCM and others were commonly known. He paid his way through college selling MRO supplies to local manufacturers, so he has seen maintenance from several perspectives.
One of his claims to fame in the software industry was overseeing a co-development project to build a world-class enterprise asset management solution for a Tier 1 ERP vendor. The co-development partner was a worldwide renowned Mining/Metals company ranked in the Fortune 100. Asset Management is in his DNA and working with customers is his passion.
Charles Carcenac is a senior operations and transformation executive with more than 20 years of experience leading large-scale industrial performance improvement programs across asset-intensive industries. He specializes in operational excellence, cost optimization, and complex transformation initiatives for global industrial organizations.
Charles has a strong track record delivering measurable EBITDA improvement through productivity enhancement, operational reliability, supply chain optimization, and large-scale operational turnaround programs. His expertise spans multi-site industrial operations, capital project execution, industrial ramp-up, and performance transformation in demanding environments.
Over the course of his career, he has led strategic and operational initiatives involving manufacturing, procurement, engineering, maintenance, and digital transformation, helping organizations improve efficiency, accelerate execution, and strengthen operational resilience.
With a hands-on and results-driven approach, Charles supports heavy industry players in addressing critical challenges related to operational performance, asset productivity, cost competitiveness, and sustainable industrial transformation.
Candy is a practical problem-solver and collaborative team-builder who has worked with the SQC team since 2005. He brings clarity to complex situations, getting teams and suppliers to perform, and drives delivery in uncertain or challenging conditions. Committed to achieving tangible results for customers, Candy has supported projects for organisations including the Prudential, M&G, Ageas, Deutsche Bank, HSBC, BT, Vodafone, and O2.
